Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 60
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Euro Surveill ; 18(13)2013 Mar 28.
Artículo en Inglés | MEDLINE | ID: mdl-23557972

RESUMEN

Injection anthrax was described first in 2000 in a heroin-injecting drug user in Norway. New anthrax cases among heroin consumers were detected in the United Kingdom (52 cases) and Germany (3 cases) in 2009-10. In June 2012, a fatal case occurred in Regensburg, Bavaria. As of December 2012, 13 cases had been reported in this new outbreak from Germany, Denmark, France and the United Kingdom. We analysed isolates from 2009-10 and 2012 as well as from the first injection anthrax case in Norway in 2000 by comparative molecular typing using a high resolution 31 marker multilocus variable-number tandem repeat analysis (MLVA) and a broad single nucleotide polymorphism (SNP) analysis. Our results show that all cases may be traced back to the same outbreak strain. They also indicate the probability of a single source contaminating heroin and that the outbreak could have lasted for at least a decade. However, an additional serological pilot study in two German regions conducted in 2011 failed to discover additional anthrax cases among 288 heroin users.


Asunto(s)
Carbunco/epidemiología , Bacillus anthracis/aislamiento & purificación , Heroína , Abuso de Sustancias por Vía Intravenosa/epidemiología , Carbunco/diagnóstico , Carbunco/microbiología , Antígenos Bacterianos/inmunología , Antígenos Bacterianos/fisiología , Bacillus anthracis/genética , Toxinas Bacterianas , Técnicas de Tipificación Bacteriana , Biomarcadores , Western Blotting , Brotes de Enfermedades , Contaminación de Medicamentos/estadística & datos numéricos , Europa (Continente)/epidemiología , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Polimorfismo de Nucleótido Simple/genética , Sensibilidad y Especificidad , Abuso de Sustancias por Vía Intravenosa/complicaciones
2.
Scand J Immunol ; 66(6): 711-8, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17983421

RESUMEN

Exposure to moulds is thought to cause adverse health effects ranging from vague subjective symptoms to allergy and respiratory diseases. Until now, most studies have been emphasizing low levels of exposure. In Norwegian sawmills during the 1980s, extensively high spore counts up to 10(7) spores/m3 air were reported. By using serum samples obtained from sawmill workers during that period, in addition to control sera, we studied the antibody response of all classes and IgG subclasses to Rhizopus microsporus at different levels of exposure. Antigen specificity was further studied by Western blotting. Exposure to R. microsporus was accompanied by R. microsporus-specific antibody production against a wide range of antigenic components most likely of both protein and carbohydrate nature. Increasing levels of mould-specific IgG1, IgG2, IgG4 and IgA antibodies were associated with increased exposure, while the highest levels of exposure were associated with a somewhat reduced level of mould-specific IgE antibodies. In conclusion, the present study strongly suggests that high mould exposure can induce a strong IgG and IgA response in a dose-dependent manner.


Asunto(s)
Contaminantes Ocupacionales del Aire , Anticuerpos Antifúngicos/aislamiento & purificación , Monitoreo del Ambiente , Hongos/inmunología , Exposición Profesional , Esporas Fúngicas/inmunología , Alérgenos , Anticuerpos Antifúngicos/inmunología , Relación Dosis-Respuesta Inmunológica , Polvo/prevención & control , Ensayo de Inmunoadsorción Enzimática , Femenino , Hongos/crecimiento & desarrollo , Humanos , Hipersensibilidad/diagnóstico , Hipersensibilidad/inmunología , Inmunoglobulina E/sangre , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
3.
Clin Microbiol Infect ; 13(10): 1018-22, 2007 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17697001

RESUMEN

A multicentre study involving seven laboratories was performed using techniques recommended by the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST) to evaluate and propose quality control ranges and strains for susceptibility testing of fermentative yeasts and filamentous fungi. Participating laboratories tested the susceptibilities of a panel of 12 encoded isolates to amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole. In total, 15 lots of assay medium were tested, with one lot being common to all laboratories, and 18 144 MIC values were determined. Intra- and inter-laboratory agreements and intra-class correlation coefficients (ICCs) of the results for each drug/strain/lot combination were calculated. An average value of 85% agreement was selected for validation purposes. The average percentage of intra-laboratory agreement was 90-95%, with ICC values of 0.90-0.95 (p <0.01). Inter-laboratory reproducibility was also high, with 92% agreement and an ICC of 0.97 (p <0.01). The reproducibility was somewhat better with the common lot of assay medium (96% agreement) than with the different lots (91% agreement), but this difference was not significant. Two isolates that showed trailing growth had agreement percentages below the 85% limit selected for validation purposes and were therefore excluded from the panel of quality control strains. The recommended EUCAST methodologies were found to be highly reproducible and reliable for susceptibility testing of yeasts and filamentous fungi. Ten isolates are proposed for use as quality control strains with these EUCAST procedures.


Asunto(s)
Antifúngicos/farmacología , Hongos/efectos de los fármacos , Laboratorios/normas , Pruebas de Sensibilidad Microbiana/normas , Comités Consultivos , Aspergillus/clasificación , Aspergillus/efectos de los fármacos , Candida/clasificación , Candida/efectos de los fármacos , Europa (Continente) , Pruebas de Sensibilidad Microbiana/métodos , Control de Calidad , Estándares de Referencia , Valores de Referencia , Reproducibilidad de los Resultados
4.
Probl Tuberk Bolezn Legk ; (9): 38-43; discussion 43, 2005.
Artículo en Ruso | MEDLINE | ID: mdl-16279517

RESUMEN

The present study was undertaken to assess the results of treatment in patients with pulmonary tuberculosis in the Arkhangelsk Region in 1999 and to analyze the results of treatment in relation to the infection with Mycobacterium tuberculosis with different profiles of sensitivity to antituberculous drugs. The outcomes of treatment were assessed in relation to the infection with Mycobacterium tuberculosis with different profiles of sensitivity to antituberculous drugs in 76 patients to whom the BACTEC test was applied. Beneficial effects of therapy were recorded in 150 (63.9%) of the 235 new cases. In 29 (12.3%) patients, it ended in death, ineffective treatment was recorded in 20 (8.5%) first detected patients; 29 (12.3%) new cases discontinued treatment; the result of therapy was unknown in 7 (3.0%). There was a low efficiency of chemotherapy (26.2%), its inefficiency in 24 (39.4%) patients; treatment was discontinued in 18 (29.5%) cases and its outcome was unknown in 1 (1.6%) patient. Resistance to one antituberculous agent timely used in the effective chemotherapy regimen did not affect the outcome of treatment. The spread of drug resistance in pulmonary tuberculosis in the Arkhagelsk Region directly affects the outcome of the disease.


Asunto(s)
Antibióticos Antituberculosos/farmacocinética , Antibióticos Antituberculosos/uso terapéutico , Farmacorresistencia Bacteriana , Tuberculosis Pulmonar/tratamiento farmacológico , Tuberculosis Pulmonar/microbiología , Áreas de Influencia de Salud , Humanos , Federación de Rusia/epidemiología , Resultado del Tratamiento , Tuberculosis Pulmonar/epidemiología
5.
Clin Microbiol Infect ; 21(10): 938-45, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26093076

RESUMEN

Several studies have reported an increased incidence of candidaemia and a redistribution of species, with a decrease in the number of Candida albicans isolates. In Norway, a prospective, national surveillance study of candidaemia has been ongoing since 1991. Data from the period 1991-2003 have been published previously. The aim of this study was to follow up the incidence, species distribution and antifungal susceptibility of Candida species isolates from blood cultures in the period 2004-2012, and compare them with the corresponding findings from the period 1991-2003. Blood culture isolates of Candida species from all medical microbiological laboratories in Norway were identified and susceptibility tested at the Norwegian Mycological Reference Laboratory. A total of 1724 isolates were recovered from 1653 patients in the period 2004-2012. Comparison of the two periods showed that the average incidence of candidaemia episodes per 100 000 inhabitants increased from 2.4 (1991-2003) to 3.9 (2004-2012). The increase in incidence in the latter period was significantly higher in patients aged >40 years (p 0.001), and a marked increase was observed in patients aged >60 years (p < 0.001). In conclusion, the average incidence in Norway over a period of 22 years modestly increased from 2.4 to 3.9 per 100,000 inhabitants, this being mainly accounted for by candidaemia in the elderly. The species distribution was stable, and the rate of acquired resistance was low.


Asunto(s)
Candida/clasificación , Candida/aislamiento & purificación , Candidemia/epidemiología , Candidemia/microbiología , Adolescente , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Antifúngicos/farmacología , Candida/efectos de los fármacos , Niño , Preescolar , Farmacorresistencia Fúngica , Monitoreo Epidemiológico , Femenino , Humanos , Incidencia , Lactante , Recién Nacido , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Noruega/epidemiología , Estudios Prospectivos , Adulto Joven
6.
Shock ; 3(6): 455-61, 1995 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-7656071

RESUMEN

The aim of the study was to determine how the physical nature of a large bowel perforation influences the host inflammatory response. Two rat models were used: a 4 mm cecal perforation (CP) and a cecal ligation with 23 gauge needle puncture (CLP). CP gave a more fulminant course and this was reflected in higher levels of bacteria, endotoxin, tumor necrosis factor, interleukin-1 (IL-1), and IL-6, which were all strongly compartmentalized in the peritoneal cavity. Despite a sustained enhancement of cytokines in peritoneal fluid, only a temporary burst of tumor necrosis factor, and no release of IL-1, were seen in serum, whereas IL-6 was continuously released. Depletion of leukocytes was more pronounced in CP than CLP. In summary, a large bowel perforation like CP triggers an overwhelming host reaction with leukocytopenia, cytokine release, dehydration, hypoperfusion, and death. The smaller fecal inoculum in CLP gives a more subacute inflammatory response.


Asunto(s)
Colon/lesiones , Choque Séptico/fisiopatología , Animales , Bacteriemia/etiología , Bacteriemia/mortalidad , Citotoxinas/sangre , Endotoxinas/sangre , Masculino , Pronóstico , Ratas , Ratas Wistar , Choque Séptico/etiología , Choque Séptico/mortalidad
7.
APMIS ; 100(11): 981-7, 1992 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-1472367

RESUMEN

In sawmills high concentrations of spores from the mould Rhizopus microsporus may occur, causing allergic alveolitis in exposed workers. Both symptomatic and asymptomatic exposed workers may develop antibodies. An enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to Rhizopus has been developed in order to study the relationship between antibody levels and exposure levels. The precision of the measurements of Rhizopus antibodies by ELISA carried out on the same microtiter plate was estimated to be 11%. It is therefore possible to detect changes in antibody levels of approximately 25% or more. Antibodies were studied longitudinally by ELISA in 60 wood trimmers. The observed changes in antibody levels exceeded the precision of the ELISA method substantially, indicating significant variability in antibody levels in wood trimmers. The ELISA test was compared with the double immunodiffusion test (DID). Sera from 67 wood trimmers were analyzed by both methods. Antibodies were detected by ELISA in 70% and by DID in 28% of the workers in this group, clearly demonstrating that the ELISA test is the most sensitive method for the detection of antibodies to Rhizopus.


Asunto(s)
Anticuerpos Antifúngicos/análisis , Rhizopus/inmunología , Ensayo de Inmunoadsorción Enzimática/métodos , Inmunodifusión , Inmunoglobulina G/inmunología , Enfermedades Profesionales/inmunología , Esporas Fúngicas/inmunología , Madera
8.
Intensive Care Med ; 24(3): 206-16, 1998 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-9565801

RESUMEN

The incidence of systemic Candida infections in patients requiring intensive care has increased substantially in recent years as a result of a combination of factors. More patients with severe underlying disease or immunosuppression from anti-neoplastic or anti-rejection chemotherapy and at risk from fungal infection are now admitted to the ICU. Improvements in supportive medical and surgical care have led to many patients who would previously have died as a result of trauma or disease surviving to receive intensive care. Moreover, some therapeutic interventions used in the ICU, most notably broad-spectrum antibiotics and intravascular catheters, are also associated with increased risks of candidiasis. Systemic Candida infections are associated with a high morbidity and mortality, but remain difficult to diagnose and ICU staff need to be acutely aware of this often insidious pathogen. A number of studies have identified risk factors for systemic Candida infection which may be used to identify those at highest risk. Such patients may be potential candidates for early, presumptive therapy. Here we review the epidemiology, pathogenesis, morbidity and mortality of systemic Candida infections in the ICU setting, and examine predisposing risk factors. Antifungal treatment, including the use of amphotericin B, flucytosine and fluconazole, and the roles of early presumptive therapy and prophylaxis, is also reviewed.


Asunto(s)
Candidiasis , Cuidados Críticos , Infección Hospitalaria , Fungemia , Complicaciones Posoperatorias , Antifúngicos/uso terapéutico , Candidiasis/diagnóstico , Candidiasis/tratamiento farmacológico , Candidiasis/epidemiología , Causalidad , Infección Hospitalaria/diagnóstico , Infección Hospitalaria/tratamiento farmacológico , Infección Hospitalaria/epidemiología , Europa (Continente)/epidemiología , Fungemia/diagnóstico , Fungemia/tratamiento farmacológico , Fungemia/epidemiología , Humanos , Incidencia , Control de Infecciones , Vigilancia de la Población , Complicaciones Posoperatorias/diagnóstico , Complicaciones Posoperatorias/tratamiento farmacológico , Complicaciones Posoperatorias/epidemiología , Estados Unidos/epidemiología
9.
Microb Drug Resist ; 1(4): 321-6, 1995.
Artículo en Inglés | MEDLINE | ID: mdl-9158803

RESUMEN

Rifampin resistance in respiratory isolates of Mycobacterium tuberculosis from Mozambique was detected by screening for point mutations using polymerase chain reaction (PCR) and DNA sequence analysis. The target template was a 350-bp fragment of rpoB encoding the beta-subunit of the RNA polymerase. Of the 66 strains studied, 38 were rifampin resistant by susceptibility testing with the radiometric method, 3 were intermediately resistant, and 25 were susceptible to rifampin. In 39 of the 41 rifampin-resistant strains, base-substitutions in the rpoB fragment were detected, and a total of 13 distinct mutations affecting 6 amino acids were observed. One of these mutations (His-->Thr in amino acid 526) was not previously described. The isolates were also investigated by restriction fragment length polymorphism (RFLP) analysis using the insertion element IS6110 as a hybridization probe. A total of 47 RFLP patterns were identified, with up to 9 isolates having the same RFLP pattern. Strains with the same RFLP pattern harbored different mutations in rpoB, suggesting that acquisition of rifampin resistance followed the spread of a rifampin-susceptible clone. The data showed that rifampin resistance can be detected with a high sensitivity by DNA sequence analysis of this fragment of rpoB. However, a few strains with rifampin resistance due to factors other than base substitutions in rpoB could be missed.


Asunto(s)
Antibióticos Antituberculosos/farmacología , Mycobacterium tuberculosis/efectos de los fármacos , Rifampin/farmacología , Tuberculosis Pulmonar/microbiología , Secuencia de Aminoácidos , Secuencia de Bases , ADN Bacteriano/análisis , ADN Bacteriano/aislamiento & purificación , Farmacorresistencia Microbiana , Humanos , Pruebas de Sensibilidad Microbiana , Datos de Secuencia Molecular , Mozambique , Hibridación de Ácido Nucleico , Reacción en Cadena de la Polimerasa , Polimorfismo de Longitud del Fragmento de Restricción
10.
Int J Tuberc Lung Dis ; 6(5): 406-14, 2002 May.
Artículo en Inglés | MEDLINE | ID: mdl-12019916

RESUMEN

SETTING: The Archangels oblast, Russia, 1998-2000. OBJECTIVE: To study Mycobacterium tuberculosis resistance to anti-tuberculosis drugs in the Archangels oblast, and to reveal risk factors for the development of drug-resistant tuberculosis. DESIGN: The drug susceptibility of strains isolated from 119 patients with pulmonary tuberculosis was studied using the BACTEC method. Medical records of the patients were reviewed, retrospectively, to identify factors associated with drug resistance. RESULTS: Sixty-seven strains (56.3%) were resistant to at least one anti-tuberculosis drug. The highest rates of resistance were observed for streptomycin and isoniazid: respectively 40.4% and 66.7% of strains isolated from newly and previously treated patients were resistant to streptomycin, and respectively 37.1% and 73.3% of strains isolated from newly and previously treated patients were resistant to isoniazid. Thirty of the 119 strains (25.2%) were multidrug-resistant. Multidrug resistance was four times higher among previously treated patients than among new patients. A history of previous or interrupted treatment for tuberculosis and being female were significantly associated with drug resistance. CONCLUSION: Drug-resistant tuberculosis is an important problem in the Archangels oblast, Russia. The spread of drug resistance is attributed to several risk factors. Being female and evidence of previous treatment for tuberculosis are risk factors for the development of drug-resistant tuberculosis in the Archangels oblast. Patients with drug-resistant tuberculosis also showed a higher risk of interrupting their treatment.


Asunto(s)
Antituberculosos/uso terapéutico , Farmacorresistencia Bacteriana , Etambutol/uso terapéutico , Isoniazida/uso terapéutico , Mycobacterium tuberculosis/efectos de los fármacos , Mycobacterium tuberculosis/aislamiento & purificación , Rifampin/uso terapéutico , Estreptomicina/uso terapéutico , Tuberculosis Pulmonar/tratamiento farmacológico , Tuberculosis Pulmonar/microbiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antituberculosos/farmacología , Etambutol/farmacología , Femenino , Humanos , Isoniazida/farmacología , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Rifampin/farmacología , Factores de Riesgo , Federación de Rusia , Factores Socioeconómicos , Estreptomicina/farmacología , Tuberculosis Pulmonar/etiología
11.
Int J Tuberc Lung Dis ; 7(9): 899-902, 2003 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-12971676

RESUMEN

In the first attempt to establish a quality assurance programme for susceptibility testing of Mycobacterium tuberculosis to fluoroquinolones, 20 strains with different fluoroquinolone susceptibility patterns were distributed by the Supranational Reference Laboratory in Stockholm to the other mycobacterial reference laboratories of the Nordic and Baltic countries. Susceptibility testing to fluoroquinolones was performed according to routine procedures in each laboratory. Results were compared to sequence analysis of the gyrA gene and minimal inhibitory concentration determination. Most laboratories found identical susceptibility patterns. The two resistant strains were correctly identified by all laboratories, but three laboratories each falsely reported one susceptible strain as resistant. These results indicate that the participating laboratories yield reliable results in detection of fluoroquinolone-resistant strains, although the need for a standardised quality assurance programme for drug susceptibility testing for fluoroquinolones is stressed by the strains falsely reported as resistant.


Asunto(s)
Antituberculosos/farmacología , Resistencia a Múltiples Medicamentos , Fluoroquinolonas/farmacología , Mycobacterium tuberculosis/efectos de los fármacos , Mycobacterium tuberculosis/patogenicidad , Tuberculosis Pulmonar/tratamiento farmacológico , Países Bálticos , Farmacorresistencia Bacteriana , Reacciones Falso Positivas , Humanos , Cooperación Internacional , Laboratorios , Pruebas de Sensibilidad Microbiana , Noruega , Valores de Referencia , Reproducibilidad de los Resultados , Suecia
12.
Clin Microbiol Infect ; 17(12): 1875-81, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21745258

RESUMEN

A longitudinal, prospective study was conducted intermittently in Norway, from 1999 to 2008, to investigate the Candida colonization rates and species distributions in the tonsillopharyngeal and faecal flora in: (i) children with cancer; (ii) children with cystic fibrosis (CF); and (iii) healthy children. The effect of antibiotic treatment on Candida colonization was also studied, and we looked for changes in antifungal susceptibility over time within each child and between the different groups of children. In total, 566 tonsillopharyngeal swabs and 545 faecal samples were collected from 45 children with cancer, 37 children with CF, and 71 healthy, age-matched controls. The overall colonization rate with Candida was not significantly higher in the two groups of children undergoing extensive treatment with broad-spectrum antibiotics than in healthy controls. Approximately one-third of the cancer patients had a total lack of Candida colonization or had only one Candida-positive sample, despite multiple samples being taken, treatment with broad-spectrum antibiotics, long hospital stays, and periods with neutropenia. Children with CF had the highest prevalence of Candida albicans. Amoxycillin, azithromycin, third-generation cephalosporins and oral vancomycin resulted in a significantly increased Candida colonization rate. Phenoxymethylpenicillin, second-generation cephalosporins, metronidazole, trimethoprim-sulphamethoxazole, ciprofloxacin, penicillinase-resistant penicillins and inhaled tobramycin or colistin showed minimal effects on the Candida colonization rate. We found no evidence of development of antifungal resistance over time.


Asunto(s)
Candida/clasificación , Candidiasis/epidemiología , Fibrosis Quística/complicaciones , Neoplasias/complicaciones , Adolescente , Antibacterianos/uso terapéutico , Antifúngicos/farmacología , Candida/efectos de los fármacos , Candida/aislamiento & purificación , Niño , Preescolar , Heces/microbiología , Humanos , Lactante , Estudios Longitudinales , Pruebas de Sensibilidad Microbiana , Noruega/epidemiología , Tonsila Palatina/microbiología , Faringe/microbiología , Prevalencia , Estudios Prospectivos
14.
Rev Iberoam Micol ; 17(3): 73-81, 2000 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15762797
15.
J Antimicrob Chemother ; 57(5): 987-91, 2006 May.
Artículo en Inglés | MEDLINE | ID: mdl-16524896

RESUMEN

OBJECTIVES: To evaluate the inexpensive colorimetric nitrate reductase-based antibiotic susceptibility (CONRAS) assay for testing the susceptibility of Mycobacterium tuberculosis to streptomycin and ethambutol in liquid cultures, and to compare the CONRAS test with the manual mycobacteria growth indicator tube (MGIT) test, using the radiometric BACTEC 460TB method as reference. METHODS: A total of 89 M. tuberculosis isolates were tested for susceptibility to streptomycin and ethambutol using the CONRAS and manual MGIT methods and the results were compared with BACTEC 460TB. Isolates with discrepant results between the CONRAS test and BACTEC 460TB were analysed using the agar proportion method, Etest and mutation analysis of genes involved in resistance to streptomycin and ethambutol. RESULTS: The agreement between the CONRAS test and BACTEC 460TB was 88% for streptomycin and 84% for ethambutol. The corresponding agreement of the manual MGIT test with BACTEC 460TB was 89 and 80%, respectively. There was good agreement for streptomycin and moderate agreement for ethambutol between the CONRAS and manual MGIT tests on one hand and BACTEC 460TB on the other (CONRAS test, kappa(streptomycin) 0.74 and kappa(ethambutol) 0.59, P < 0.001; manual MGIT test, kappa(streptomycin) 0.77 and kappa(ethambutol) 0.50, P < 0.001). CONCLUSIONS: There is good agreement for the two non-radiometric liquid culture methods (CONRAS and manual MGIT) compared with BACTEC 460TB for the detection of streptomycin resistance. Further standardization is needed for testing of ethambutol resistance using the CONRAS and manual MGIT assays.


Asunto(s)
Antituberculosos/farmacología , Farmacorresistencia Bacteriana , Etambutol/farmacología , Mycobacterium tuberculosis/efectos de los fármacos , Nitrato-Reductasa/química , Estreptomicina/farmacología , Colorimetría/métodos , Farmacorresistencia Bacteriana/genética , Pruebas de Sensibilidad Microbiana/métodos , Mycobacterium tuberculosis/genética , Mycobacterium tuberculosis/aislamiento & purificación , Reproducibilidad de los Resultados , Sensibilidad y Especificidad
16.
Eur J Clin Microbiol Infect Dis ; 24(3): 202-6, 2005 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15742171

RESUMEN

Multidrug-resistant tuberculosis has become common all over the world, necessitating the inclusion of second-line drugs in treatment regimens. In the present study, the susceptibility of a selection of multidrug-resistant strains of Mycobacterium tuberculosis isolated in the Archangel oblast, Russia, to second-line anti-tuberculosis drugs was analysed. Susceptibility testing of 77 Mycobacterium tuberculosis strains was performed by the Bactec method using the following recommended drug concentrations: capreomycin 1.25 microg/ml; ethionamide 1.25 microg/ml; kanamycin 5 microg/ml; and ofloxacin 2 microg/ml. The majority of strains (92.2%) were resistant to ethionamide. High rates of drug resistance were also found for capreomycin (42.9%) and kanamycin (41.6%), while nearly all strains (98.7%) were susceptible to ofloxacin. The high rates of resistance to ethionamide, capreomycin, and kanamycin show the real burden of drug resistance in the region and pose a serious problem for the treatment of patients with multidrug-resistant tuberculosis.


Asunto(s)
Antituberculosos/farmacología , Farmacorresistencia Bacteriana Múltiple , Mycobacterium tuberculosis/efectos de los fármacos , Capreomicina/farmacología , Etionamida/farmacología , Humanos , Kanamicina/farmacología , Ofloxacino/farmacología , Federación de Rusia , Tuberculosis Pulmonar/microbiología
17.
Thorax ; 60(2): 136-7, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15681502

RESUMEN

BACKGROUND: Traditional contact investigation is an important tool for controlling tuberculosis. It may also help to indicate drug susceptibility patterns when Mycobacterium tuberculosis cultures are not available. Such investigations often underestimate the degree of transmission found by genotyping, but overestimation may also occur. This report is the result of a routine successive DNA restriction fragment length polymorphism (RFLP) analysis of M tuberculosis isolated in Norway. METHOD: Fifteen immigrants belonging to the same community were notified with tuberculosis during February to September 2003. The mycobacterial isolates were analysed by RFLP. RESULTS: All 15 patients had social contact with each other and 13 belonged to the same church community. A total of 14 cultures were positive for M tuberculosis. Among these isolates, six different genotypes were found. Five patients had not acquired the infection from the putative source. CONCLUSIONS: Reactivation of tuberculosis may occur in contacts during the development of an outbreak. In such situations, traditional contact investigations may overestimate the rate of transmission found by genotyping of M tuberculosis. When cultures are unavailable and presumed drug susceptibility patterns are based on that of contacts, such overestimation may lead to incorrect treatment of a patient. Contact investigations must be combined with genotyping of M tuberculosis to conclude how tuberculosis is transmitted. This is especially important in persons with several risk factors for infection.


Asunto(s)
Trazado de Contacto , Mycobacterium tuberculosis/genética , Tuberculosis/transmisión , Adolescente , Adulto , Niño , Preescolar , ADN Bacteriano/genética , Emigración e Inmigración , Femenino , Genotipo , Humanos , Lactante , Masculino , Noruega , Polimorfismo de Longitud del Fragmento de Restricción , Factores de Riesgo , Tuberculosis/genética
18.
J Clin Microbiol ; 37(12): 3856-9, 1999 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-10565896

RESUMEN

A commercial disc diffusion test has been evaluated as a screening method for the detection of Candida species with decreased susceptibility to fluconazole. A total of 1,407 Candida strains of different species were tested, and the results were compared with the MIC results. The recently published National Committee for Clinical Laboratory Standards breakpoint criteria have been used. Isolates were classified as susceptible if the MIC for the isolates was /=64 microg/ml. All 77 resistant strains and 121 of 122 S-DD strains had fluconazole zone diameters of

Asunto(s)
Antifúngicos/farmacología , Candida/efectos de los fármacos , Candidiasis/microbiología , Fluconazol/farmacología , Pruebas de Sensibilidad Microbiana/métodos , Candida albicans/efectos de los fármacos , Difusión , Farmacorresistencia Microbiana , Humanos
19.
Tidsskr Nor Laegeforen ; 109(3): 357-60, 1989 Jan 30.
Artículo en Noruego | MEDLINE | ID: mdl-2916221

RESUMEN

A hypothesis concerning a chronic candida hypersensitivity syndrome caused by the presence of Candida albicans in the gut was put forward in the USA a decade ago. Lately this theory has gained much publicity in Norway through articles in the press and programs on the national radio and television. The purpose of this article is to give a presentation and critical evaluation of this syndrome. It is concluded that the theory of a chronic Candida hypersensitivity syndrome is speculative and devoid of experimental support.


Asunto(s)
Candidiasis/epidemiología , Humanos , Enfermedades Intestinales/epidemiología , Enfermedades Intestinales/etiología
20.
Acta Odontol Scand ; 48(1): 27-36, 1990 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-1690944

RESUMEN

Methods used for identification and sensitivity testing of yeasts are presented. Identification depends on both morphologic features and biochemical characteristics. The germ tube test is a simple test for the identification of the commonest yeast pathogen, Candida albicans. Species not identified by this method can be identified by means of several other tests, the most important being the carbohydrate assimilation test. Several kits are commercially available and most appear to be satisfactory. Antifungal susceptibility tests are not standardized, and results are often subject to considerable variation. Until improved methods are developed, it might be advisable that smaller laboratories only do a preliminary screening test for flucytosine susceptibility and, if indicated, also for amphotericin B susceptibility. Important isolates should be sent to laboratories with a special interest in antifungal susceptibility testing for more extensive testing.


Asunto(s)
Antifúngicos/farmacología , Micosis/microbiología , Levaduras/aislamiento & purificación , Candida/efectos de los fármacos , Candida/aislamiento & purificación , Metabolismo de los Hidratos de Carbono , Humanos , Pruebas de Sensibilidad Microbiana , Técnicas Microbiológicas , Coloración y Etiquetado , Levaduras/efectos de los fármacos , Levaduras/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA